Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER.

MLA

Desai, Akshay S., et al. “Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER.” JAMA Cardiology, vol. 7, no. 12, Dec. 2022, pp. 1227–34. EBSCOhost, https://doi.org/10.1001/jamacardio.2022.3736.

APA

Desai, A. S., Jhund, P. S., Claggett, B. L., Vaduganathan, M., Miao, Z. M., Kondo, T., Barkoudah, E., Brahimi, A., Connolly, E., Finn, P., Lang, N. N., Mc Causland, F. R., McGrath, M., Petrie, M. C., McMurray, J. J. V., & Solomon, S. D. (2022). Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER. JAMA Cardiology, 7(12), 1227–1234. https://doi.org/10.1001/jamacardio.2022.3736

Chicago

Desai, Akshay S, Pardeep S Jhund, Brian L Claggett, Muthiah Vaduganathan, Zi Michael Miao, Toru Kondo, Ebrahim Barkoudah, et al. 2022. “Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER.” JAMA Cardiology 7 (12): 1227–34. doi:10.1001/jamacardio.2022.3736.